MedTrace Logo

Application Value of CTCs Detection for Advanced Gastric Cancer Patients

NCT03156777 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2017-05-17

No results posted yet for this study

Summary

Evaluating the application value of a new circulating tumor cell detection method for advanced gastric cancer patients in prediction of the prognosis and early evaluation of the result of postoperation adjuvant chemotherapy.

Conditions

Sponsors & Collaborators

  • Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

    lead OTHER

Principal Investigators

  • Wei Lu, M.D. & Ph.D. · Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

  • Yinbing Liu, M.D. & Ph.D. · Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2018-12-31
Completion
2020-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03156777 on ClinicalTrials.gov